LNTH

#1009
Lantheus Holdings, Inc. - Common Stock
99.3 0 USD
-0.32%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
99.30
99.30
년간 변동
0.95
103.89
일일 변동
-0.32%
월간 변동
+22.34%
6달 변화
+70.01%
년간 변동율
+77.13%
이전 종가
99.6 2
Open
99.3 0
저가
99.3 0
High
99.3 0
양
209
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 6.47 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
19.52
주가매출액비율
2.95

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

뉴스